Resilient Biotics


Resilient Biotics is dedicated to developing innovative microbiome products and therapies to combat respiratory diseases and reduce dependency on antibiotics. The company leverages advanced genomics, data science, and microbiome research to create targeted solutions for both human and animal health, aiming to eliminate disease, reduce antibiotic resistance, and promote host well-being.

Industries

analytics
biotechnology
therapeutics

Nr. of Employees

small (1-50)

Resilient Biotics

Raleigh, North Carolina, United States, North America


Products

Aerosol-delivered multi-strain live biotherapeutic for respiratory disease in production animals

A live microbial therapeutic formulated as multi-strain mixtures and designed for aerosol delivery to the respiratory tract to prevent pathogen colonization and reduce infection severity in livestock.


Services

Data-driven discovery service combining proprietary multi-omic databases, machine learning, and bioinformatics to identify microbial leads and predictive biomarkers.

Discovery and experimental validation service offering strain isolation, targeted functional assays, and formulation optimization for live biotherapeutic candidates.

Expertise Areas

  • Microbiome therapeutics
  • Microbiome data analytics and biomarker discovery
  • Bioinformatics and multi-omics integration
  • Strain isolation, curation and library management
  • Show More (4)

Key Technologies

  • Multi-omics sequencing and analysis
  • Deep learning and Bayesian statistical models
  • Strain-level taxonomic profiling
  • Functional in vitro and ex vivo screening assays
  • Show More (3)

News & Updates

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.